Vineet Laboratories Ltd

BOM:543298 (India)   Ordinary Shares
₹ 59.03 (+0.07%) Sep 20
393.54
P/B:
1.67
Market Cap:
₹ 544.20M ($ 6.52M)
Enterprise V:
₹ 984.92M ($ 11.80M)
Volume:
582.00
Avg Vol (2M):
15.09K
Trade In:
Volume:
582.00
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Vineet Laboratories Ltd ( ) from 2021 to Sep 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Vineet Laboratories stock (BOM:543298) PE ratio as of Sep 21 2024 is 393.54. More Details

Vineet Laboratories Ltd (BOM:543298) PE Ratio (TTM) Chart

To

Vineet Laboratories Ltd (BOM:543298) PE Ratio (TTM) Historical Data

Total 806
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 9
Vineet Laboratories PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-09-21 393.5 2024-07-19 386.9
2024-09-20 393.5 2024-07-18 392.3
2024-09-19 393.3 2024-07-16 410.9
2024-09-18 395.9 2024-07-15 427.1
2024-09-17 398.8 2024-07-12 420.3
2024-09-16 403.4 2024-07-11 432.0
2024-09-13 401.0 2024-07-10 427.5
2024-09-12 404.0 2024-07-09 421.8
2024-09-11 403.8 2024-07-08 417.5
2024-09-10 397.3 2024-07-05 433.7
2024-09-09 399.7 2024-07-04 391.4
2024-09-06 395.5 2024-07-03 392.3
2024-09-05 403.2 2024-07-02 400.0
2024-09-04 413.4 2024-07-01 383.5
2024-09-03 386.1 2024-06-28 388.3
2024-09-02 394.6 2024-06-27 53.5
2024-08-30 394.5 2024-06-26 53.0
2024-08-29 402.1 2024-06-25 53.0
2024-08-28 420.3 2024-06-24 55.3
2024-08-27 418.5 2024-06-21 57.0
2024-08-26 419.3 2024-06-20 54.0
2024-08-23 414.3 2024-06-19 53.3
2024-08-22 414.1 2024-06-18 54.4
2024-08-21 409.9 2024-06-14 55.5
2024-08-20 408.2 2024-06-13 56.4
2024-08-19 413.2 2024-06-12 56.2
2024-08-16 397.1 2024-06-11 54.5
2024-08-14 391.9 2024-06-10 53.6
2024-08-13 431.0 2024-06-07 55.3
2024-08-12 428.3 2024-06-06 53.0
2024-08-09 413.0 2024-06-05 54.1
2024-08-08 422.3 2024-06-04 50.5
2024-08-07 430.5 2024-06-03 52.5
2024-08-06 394.7 2024-05-31 50.1
2024-08-05 403.7 2024-05-29 53.5
2024-08-02 422.1 2024-05-28 51.1
2024-08-01 447.0 2024-05-27 55.6
2024-07-31 473.3 2024-05-24 47.9
2024-07-30 441.5 2024-05-23 48.1
2024-07-29 392.5 2024-05-22 47.0
2024-07-26 394.2 2024-05-21 47.3
2024-07-25 382.1 2024-05-17 49.5
2024-07-24 378.3 2024-05-16 47.9
2024-07-23 367.8 2024-05-15 49.5
2024-07-22 382.7 2024-05-14 47.8

Vineet Laboratories Ltd (BOM:543298) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Vineet Laboratories Ltd Formerly known as Ortin Laboratories Limited, Unit-II is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Isopropyl-beta-D-thiogalactopyranoside and Nitrophenyl phosphate disodium salt among others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, manufacture of Drug Intermediates & Bulk Dugs.